Back

Fibrosis-4 (FIB-4) score is associated with early diastolic dysfunction in metabolic dysfunction-associated steatotic liver disease (MASLD)

30 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Cardiac structure, function, and symptoms in cardiometabolic and systemic disease Systolic and Diastolic Function ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Sung Kee Ryu

Ewha Womans University Seoul Hospital, Seoul (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail
Associations between cardiac biomarkers and cardiac structure and function in patients with psoriasis
Doctor J. Borchsenius (Hellerup, DK)
Abstract Slides Video
Presentation thumbnail
Cardiovascular-kidney-metabolic (CKM) syndrome stage is associated with impaired cardiac structure/function and increased symptom burden in patients with MASLD
Mr A. Reimer Jensen (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
Prevalence of cardiac dysfunction and symptoms in long COVID
Ms Z. Hassan Juma (DK)
Abstract Slides Video
Presentation thumbnail
Global myocardial performance and long-term mortality after TAVI: prognostic value of the TEI index
Doctor N. Clodi (Salzburg, AT)
Abstract Slides Video
Presentation thumbnail
The cystatin c–to–creatinine eGFR ratio and subclinical cardiac structure and function in a population-based cohort
Mr H. Zilic (Malmo, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac structure, function, and symptoms in cardiometabolic and systemic disease

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Significant association between left ventricular diastolic dysfunction, left atrial performance and liver stiffness in patients with metabolic syndrome and non-alcoholic fatty liver disease
29 June 2021
thumbnail
Congress Presentation
Clinical utility of the FIB-4 index for predicting cardiovascular outcomes in patients with metabolic dysfunction-associated steatotic liver disease: a 10-year retrospective cohort study
30 August 2025
thumbnail
Congress Presentation
Derivation and validation of a novel score to detect heart failure with preserved ejection fraction in patients with atrial fibrillation: The Fushimi AF registry
28 August 2020
thumbnail
Congress Presentation
Circulating pro fibrotic protein promotes fibrosis in liver and heart
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources